INTERNATIONAL PATENT: ARJIL BIOTECH HOLDING COMPANY LIMITED, WU, YEH B. FILES APPLICATION FOR "ANTI-CANCER DERIVATIVES OF OVATODIOLIDE AND USE THEREOF"

GENEVA, Dec. 2 -- ARJIL BIOTECH HOLDING COMPANY LIMITED (R209, Building A, 4th General Building, NTHU, No. 101, Sec. 2, Kuang-Fu Rd., East Dist.Hsinchu City, 300044), WU, Yeh B. (c/o ARJIL BIOTECH HOLDING COMPANY LIMITEDR209, Building A, 4th General Building, NTHU, No. 101, Sec. 2, Kuang-Fu Rd., East Dist.Hsinchu City, 300044) filed a patent application (PCT/US2025/029744) for "ANTI-CANCER DERIVATIVES OF OVATODIOLIDE AND USE THEREOF" on May 16, 2025. With publication no. WO/2025/244951, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO). ...